Ying X. Gue

Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial

Derek J. Hausenloy, Rajesh Kharbanda, Ulla Møller et al. · The Lancet · 2019 · 309 citations · Full text

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Impaired endogenous fibrinolysis in ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention is a predictor of recurrent cardiovascular events: the RISK PPCI study

Mohamed Farag, Nikolaos Spinthakis, Ying X. Gue et al. · European Heart Journal · 2018 · 88 citations · Full text

Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: A Position Paper from the ESC Working Group on Thrombosis, in collaboration with the European Heart Rhythm Association, the Association for Acute CardioVascular Care and the Asia-Pacific Heart Rhythm Society

Diana A. Gorog, Ying X. Gue, Tze‐Fan Chao et al. · EP Europace · 2022 · 60 citations · Full text

Development of a novel risk score to predict mortality in patients admitted to hospital with COVID-19

Ying X. Gue, Maria Tennyson, Jovia Gao et al. · Scientific Reports · 2020 · 41 citations · Full text